KRAS and Patent ductus arteriosus: PDA can originate from other pancreatic epithelial cells (i.e., ductal cells), which are however more refractory to the sole effect of oncogenic KRAS and may require the synergism of different oncogenes, or alternatively give rise to less common, more benign, precursor lesions [20,27,28].